| Inclusion criteria | Exclusion criteria |
---|---|---|
Age | Adults aged 18 years or over | Participants under the age of 18 |
Capacity | All participants must be able to give informed consent | Unable to give informed consent |
Joint hypermobility | Diagnosis of hEDS/HSD/JHS OR Score of 2 or more on 5-point questionnaire to detect joint hypermobility | No diagnosis of hEDS/HSD/JHS AND score of 1 or less on 5 point questionnaire to detect joint hypermobility |
Anxiety | Self-reported lived experience of anxiety disorder AND A score of 16 or more on Beck Anxiety Inventory endorsing moderate anxiety level AND Anxiety should be the primary psychiatric problem | No self-reported lived experience of anxiety disorder OR A score of 15 or less on Beck Anxiety Inventory OR Anxiety is not the primary psychiatric problem |
Other psychiatric disorder | No presence of major psychiatric disorder, except co-morbid depression | Presence of major psychiatric disorder (other than co-morbid depression), e.g. bipolar affective disorder, schizophrenia or psychosis OR personality disorder (e.g. emotionally unstable personality disorder) OR diagnosed neurodevelopmental disorder such as attention deficit hyperactivity disorder or autism spectrum condition OR neurological disorder |
Medication use | All participants should be on a stable dose of medication for 3 months OR Medication free AND willing to consider omitting medication that directly affects heart rate (e.g. beta blockers) during the trial | Not on a stable dose of medication (or medication free) for 3 months |
Language | All participants must have a reasonable level of both written and spoken English as therapies and assessments will be conducted in English | Poor level of both written and spoken English |
Therapy | Not receiving another modality of talking therapy | Currently receiving another modality of talking therapy |